|Videos|January 10, 2022

Expert Discusses How DMT Differs From Other Psychedelic Medicines

Carol Routledge, PhD, chief medical and scientific officer at Small Pharma, discusses DMT, how it differs from other psychedelic medicines, and what the future holds for DMT-assisted treatments.

Carol Routledge, PhD, chief medical and scientific officer at Small Pharma, discussed DMT, how it differs from other psychedelic medicines, and what the future holds for DMT-assisted treatments.

She spoke about the benefits of DMT, what the treatment targets are, and early research of the drug.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Virtual Event

Cardiology Day of Education 2026

Thursday, June 4, 2026

Virtual Conference

Immunology Specialty Pharmacy Day of Education 2026

Wednesday, June 10, 2026

Panel Discussion Registration

The Educated Pharmacist: Using Patient Insights to Personalize Insulin Therapy and Prevent Clinical Inertia

Thursday, June 25, 2026 | 1:00 PM – 2:30 PM EDT

Virtual Event

Breast Cancer Day of Education 2026

Tuesday, July 14, 2026

Virtual Event

Neuropsychiatry Day of Education 2026

Thursday, July 16, 2026

Webinar Registration

Outsmart the Algorithm: Combatting Misinformation at the Pharmacy Counter

Monday, July 22, 2026 | 1:00 PM & 8:00 PM

On-Demand Virtual Symposium

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

1.5 Credits / Psychiatry

Expert Discusses How DMT Differs From Other Psychedelic Medicines

Related Content

Expanding the Field: Who Now Qualifies for CGM, AID, and Continuous Ketone Monitoring?

Depression Common in Asthma, But Moderate to Severe Disease Worsens Outcomes

FDA Grants Priority Review to Finerenone for Chronic Kidney Disease in Adults With Type 1 Diabetes

World Schizophrenia Day: One Pharmacist's Vision for Safer Schizophrenia Care

The CGM Data Point Pharmacists Should Always Check First

Latest CME

Cardiology Day of Education 2026

Immunology Specialty Pharmacy Day of Education 2026

The Educated Pharmacist: Using Patient Insights to Personalize Insulin Therapy and Prevent Clinical Inertia

Breast Cancer Day of Education 2026

Neuropsychiatry Day of Education 2026

Outsmart the Algorithm: Combatting Misinformation at the Pharmacy Counter

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Stimulant Stewardship: A Pharmacist’s Guide to ADHD Prescribing During Drug Shortages

Not All Bispecifics Are Equal: Mechanism-Based Approaches to Selection and Management in Oncology Practice

Enhancing Patient Outcomes in Metastatic Colorectal Cancer: Equipping Community, Veterans Affairs, and Oncology Pharmacists to Navigate Care in the Third-Line Setting and Beyond

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

A Deep Dive Into CGM Data

Improving the Care of Persons Living With Diabetes Using CGM Devices (Pharmacy Technician Credit)

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Directions in Pharmacy 2026

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

Neuropsychiatry Day of Education 2026

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights (Pharmacy Technician Credit)

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

New Therapeutic Targets in the Treatment of Generalized Myasthenia Gravis: Understanding Disease Pathways and Pharmacist-Led Strategies for Optimized Care

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Cool Solutions: Non-Hormonal Advances in Vasomotor Symptoms Treatment

Cardiology Day of Education 2026

Immunology Specialty Pharmacy Day of Education 2026

Oncology Pharmacists Connect 2026

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

Targeting Genomic Drivers to Optimize ROS1-Directed Therapy in NSCLC

From Molecule to Medication: Integrating Menin Inhibitors in AML Practice

Breast Cancer Day of Education 2026

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Beyond the Nasal Passage: Managing Chronic Rhinosinusitis With Nasal Polyps With Biologics and Pharmacist-Led Approaches

Navigating the Complexities of Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer in Older Adults: Personalized Treatments for a Vulnerable Population

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches